AmericanHHM
BD - Earth day 2024

EndoClot® Distribution by Olympus Demonstrates Consistent Growth in the U.S

Saturday, March 02, 2024

Olympus, a prominent global medtech company renowned for its innovative solutions in medical and surgical procedures, announced a significant expansion of EndoClot® products across the United States. According to the recent disclosure, EndoClot products are now being utilized in 49 states, including the District of Columbia and Guam. Since 2022, when Olympus became the exclusive U.S. distributor of EndoClot hemostasis and submucosal injection solutions, over 5,000 EndoClot kits have been dispatched to customers across the nation. These products are being utilized by over 700 accounts, including major Integrated Delivery Networks (IDNs) throughout the country.

Recognizing the pivotal role of EndoClot technology in enhancing procedural efficiency and patient outcomes, Olympus partnered with EndoClot Plus, Inc. (EPI) in 2022 to bring EndoClot® Polysaccharide Hemostatic Spray (PHS) and EndoClot® Submucosal Injection Solution (SIS) to the U.S. market. These products build upon earlier agreements in the Europe, Middle East, and Africa (EMEA) region.

The innovative EndoClot AMP® technology, which powers both PHS and SIS, offers an excellent safety profile. By absorbing water from blood, EndoClot AMP particles facilitate the concentration of platelets, red blood cells, and coagulation proteins, accelerating the body's clotting cascade. Notably, these particles are biocompatible, bioabsorbable, non-pyrogenic, and devoid of animal or human components.

The EndoClot PHS System enables physicians to apply advanced powder hemostats during procedures, utilizing controlled air pressure through a portable compressor. This system, indicated for use within the gastrointestinal (GI) tract, facilitates hemostasis of nonvariceal gastrointestinal bleeding and features easy irrigation capabilities, precise delivery control, and an anti-reflux design to effectively treat challenging bleeds.

Similarly, the EndoClot SIS System serves as an essential tool for submucosal lift in gastrointestinal endoscopic procedures. Its long-lasting, high lift capability facilitates easy dissection, while its specialized spiral syringe design ensures accurate delivery to targeted areas, minimizing residual artifacts.

With its widespread adoption and proven efficacy, the Olympus EndoClot system continues to redefine gastrointestinal interventions, empowering healthcare professionals with innovative solutions for improved patient care.

Source prnewswire.com

 

 

Healthcare CEO & Executive Strategy SummitHealthcare CNO SummitHealthcare CMO SummitHealthcare CFO, Financial Strategy & Revenue Cycle SummitThe Healthcare Patient Experience & Engagement Summit 2024Healthcare Innovation & Transformation Summit